Smartlab Europe

Amedra re-launches Adrenaclick to treat anaphylaxis

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Egypt-Takeda Pharmaceutical Cooperation Boosts R&D Push

Egypt is stepping up its push to reinforce its...

Online Medicine in India Where Ganaton Total Fits in Modern Digestive Care

The demand for online medicine delivery in India has...

Roche AI Factory Expansion to Boost Pharma R&D Capacity

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure...
- Advertisement -

Amedra Pharmaceuticals has re-launched a single-dose epinephrine auto-injector Adrenaclick for people with increased risk of anaphylaxis in both 0.15mg and 0.30mg strengths.

Potentially life-threatening allergic reaction, Anaphylaxis onsets rapidly and may cause severe swelling, breathing problems, loss of blood pressure, and death.

Indicated for the treatment of allergic reactions, Adrenaclick will be made available in 0.15mg and 0.30mg doses as two-pack carton.

The emergency injection (shot) of epinephrine is used for allergic reactions caused due to stinging and biting insects (bugs), allergy injections, food, medicines, exercise, or unknown causes.

 

Latest stories

Related stories

Egypt-Takeda Pharmaceutical Cooperation Boosts R&D Push

Egypt is stepping up its push to reinforce its...

Online Medicine in India Where Ganaton Total Fits in Modern Digestive Care

The demand for online medicine delivery in India has...

Roche AI Factory Expansion to Boost Pharma R&D Capacity

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure...

Enhertu Priority Review in HER2-Positive Early Breast Cancer

The supplemental Biologics License Application - sBLA for Enhertu...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »